Navigation Links
Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders
Date:10/26/2011

a peptide-based drug for the treatment of strokes, myocardial infarction, pulmonary embolism, and venous infarction – conditions that have large target markets evaluated at billions of dollars per year.  The drug is based on the research of Prof. Abd Higazi, from Hadassah Hospital and the University of Pennsylvania. In June 2011, Thrombotech announced the start of a Phase II trial in Israel and the plans to expand the trial to some six additional sites in Israel and around the world. A regulatory permit from India has been granted and the beginning of the trial in other Israeli sites in Europe and the US is expected in Q1 of 2012.

ProtAb Ltd.

ProtAb is focused on the development of drugs for the treatment of Rheumatoid Arthritis and other autoimmune diseases. The drug is based on research by Prof. Yaakov Naparstek, the Head of Internal Medicine at Hadassah Hospital.  After successfully producing humanized antibodies, the company is in the final stages of drug scale-up under GMP conditions, and is in preparation for Phase I/II clinical trials -- which are expected to commence at the beginning of 2012.

Enlivex Ltd.

Enlivex is developing cell therapy for autoimmune diseases, and is currently nearing the end of a Phase I/II clinical trial. From initial findings received from treatment groups, the treatment seems to be safe and effective in reducing graft-versus-host disease (GVHD) in patients receiving bone marrow transplants. The company believes that it can receive approval from the FDA for orphan drug recognition, a status that permits the speeding up of regulatory procedures and provides commercial advantages. There are ongoing negotiations with potential partners – financial and scientific alike.  

BioMarCare Technologies Ltd.

BioMarCare Technologies announced the receipt of a prestigious grant from the BIRD Fund ($900,000) for the support of a joint proj
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
2. CTI Receives NASDAQ Letter
3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... 2014 Deep Research Report on Global ... in-depth research report on the China Linalool market. ... its definition, classification, application, and industry chain structure ... the international market analysis, including China’s domestic market ... environment & economic situation analysis. The report on ...
(Date:8/18/2014)... Sterne, Kessler, Goldstein & Fox P.L.L.C. , an intellectual ... , announced today that it has filed eleven petitions ... U.S. Patent and Trademark Office (USPTO) on behalf of ... BRLI).  These IPR petitions aim to nullify eleven patents ... patents have been asserted against GeneDx in patent infringement ...
(Date:8/18/2014)... According to the new ... (Municipal Wastewater Treatment and Industrial Wastewater Treatment), By ... By Configuration (Internal/Submerged and External/Sidestream), and By Region-Trends ... market for membrane bioreactor systems is projected to ... CAGR of 15.28% between 2014 and 2019. ...
(Date:8/18/2014)... 18. August 2014 Vier führende ... internationale klinische Studie auf, in der eine ... soll das Sehvermögen bei allen Entfernungen verbessern, ... möglicherweise keine Lese- oder Gleitsichtbrille mehr benötigen. ... FluidVision Accommodating Intraocular Lens (FluidVision ...
Breaking Biology Technology:Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
... Ariz., April 23 ImaRx Therapeutics,Inc. (Nasdaq: ... into an agreement,with Abbott Laboratories pursuant to which ... non-recourse promissory note with Abbott issued in,connection with ... title to,the urokinase assets, including the remaining inventory ...
... (NYSE: SGP ) today announced two agreements ... in Europe. These agreements are,in connection with conditions ... its October 2007 clearance of Schering-Plough,s acquisition of ... In two separate agreements, Pfizer and Virbac, ...
... today,announced that on April 22, 2008 its management ... Emerging Business Awards, known as the "Bennies.",BioNanomatrix won ... group of growing entrepreneurial firms in the Philadelphia ... the,award on behalf of the company., The ...
Cached Biology Technology:ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe 2BioNanomatrix Named 'Best Management Team' at the 2008 Ben Franklin Emerging Business Awards 2
(Date:8/19/2014)... other science courses are increasingly being asked to ... have a new textbook to help them do ... month by Princeton Press and co-authored by scientists ... Synthesis (NIMBioS), teaches readers about basic mathematical and ... and explain biological phenomena. , Suitable for entry-level ...
(Date:8/19/2014)... LIVERPOOL, UK 19 August 2014: An engineer at ... around, despite not having a brain to communicate with ... at Harvard, Professor L Mahadevan, has developed a mathematical ... traditional view of how these soft bodied animals get ... of the central pattern generator (CPG) which states that ...
(Date:8/19/2014)... to treat pain, but its effect on pain ... a recent study reported on the Neural ... rat models of an avulsion injury to the ... neuropathic pain) were given electroacupuncture stimulation at bilateral ... (GB34). After electroacupuncture therapy, chronic neuropathic pain in ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2Secrets of how worms wriggle uncovered 2
... have elucidated a key mechanism by which cancer cells ... and raw materials required to sustain runaway growth. ... Ludwig Cancer Research study also reveals how the aggressive ... therapies that should disrupt this capabilityknown as the Warburg ...
... animals will choose to steer clear of dirt but their ... risk of disease as a result. A study of ... near to used nesting material and droppings left by other mice. ... opportunity to eat outweighs an increased risk of disease from other ...
... to learn that individual "molecular muscles" within cells respond to ... cells "feel" the environment and appropriately adapt their shapes and ... 20 in the journal Nature Materials , specifically sheds ... internal signals. A computer model the researchers developed, ...
Cached Biology News:Targeting cancer's sweet tooth 2Targeting cancer's sweet tooth 3Clean living is a luxury wild animals can't afford, study suggests 2Cells' 'molecular muscles' help them sense and respond to their environments 2Cells' 'molecular muscles' help them sense and respond to their environments 3
PFK-2 car (P-17)...
... contains 5 ml Dynabeads Epoxy (4.5 m). ... (epoxy) reactive groups. Ideal for coupling of ... hydrophobically on initial coupling with covalent binding ... and sulphydryll groups (SH)) occurring within 16-20 ...
LTBP-2 (7B10)...
... [198C679.2.1] to Presenilin 2 Alzheimer's disease ... the disease carry mutations in the presenilin ... protein (APP). These disease-linked mutations result in ... amyloid-beta (main component of amyloid deposits found ...
Biology Products: